Caricamento...

Cost-effectiveness of the Aerobika* oscillating positive expiratory pressure device in the management of COPD exacerbations

INTRODUCTION: COPD places a huge clinical and economic burden on the US health care system, with acute exacerbations representing a key driver of direct medical costs. Current treatments, although effective in reducing symptoms and limiting exacerbations, do not adequately target the underlying dise...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Int J Chron Obstruct Pulmon Dis
Autori principali: Khoudigian-Sinani, Shoghag, Kowal, Stacey, Suggett, Jason A, Coppolo, Dominic P
Natura: Artigo
Lingua:Inglês
Pubblicazione: Dove Medical Press 2017
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5655131/
https://ncbi.nlm.nih.gov/pubmed/29089755
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S143334
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !